These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8184615)

  • 1. [The clinico-morphological characteristics and efficacy of interferon therapy in patients with chronic delta hepatitis].
    Kokoreva LN; Zmyzgova AV; Shalygina NB; Maksimov SL
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (1):55-9. PubMed ID: 8184615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of reaferon in treating patients with protracted viral hepatitis].
    Kokoreva LN; Zmyzgova AV; Nazarenko IV
    Ter Arkh; 1994; 66(2):21-4. PubMed ID: 8160137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic hepatitis delta--the course and approaches to therapy].
    Blokhina NP; Ketiladze ES; Kelli EI; Viazov SO
    Klin Med (Mosk); 1991 Mar; 69(3):85-8. PubMed ID: 2067348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The problem of the interferon therapy of patients with chronic viral hepatitis].
    Kokoreva LN; Zmyzgova AV; Shalygina NB
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (5):101-4. PubMed ID: 8525715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term interferon treatment of chronic hepatitis D: a multicentre Italian study.
    Rosina F; Pintus C; Rizzetto M
    J Hepatol; 1990; 11 Suppl 1():S149-50. PubMed ID: 2079574
    [No Abstract]   [Full Text] [Related]  

  • 6. [The treatment of different forms of B and delta hepatitis with interferon preparations].
    Botsvadze ESh; Kuznetsov VP; Aleksishvili MM; Gogichaĭshvili ShSh
    Ter Arkh; 1991; 63(11):61-3. PubMed ID: 1810067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term evolution of chronic delta hepatitis in children.
    Bortolotti F; Di Marco V; Vajro P; Crivellaro C; Zancan L; Nebbia G; Barbera C; Tedesco M; Craxi A; Rizzetto M
    J Pediatr; 1993 May; 122(5 Pt 1):736-8. PubMed ID: 8496753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic delta infection with recombinant human interferon alpha 2c at high doses.
    Porres JC; Carreño V; Bartolomé J; Moreno A; Galiana F; Quiroga JA
    J Hepatol; 1989 Nov; 9(3):338-44. PubMed ID: 2691569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment.
    Weltman MD; Brotodihardjo A; Crewe EB; Farrell GC; Bilous M; Grierson JM; Liddle C
    J Viral Hepat; 1995; 2(1):39-45. PubMed ID: 7493293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of recombinant leukocyte alpha interferon in the treatment of chronic delta hepatitis.
    Tocci G; Antonelli L; Boumis E; Colaiacomo M; Guarascio P; Struglia C; Tossini G; Visco G
    Arch Virol Suppl; 1992; 4():306-7. PubMed ID: 1450710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of chronic delta hepatitis with interferon alfa-2b.
    Di Bisceglie AM; Martin P; Lisker-Melman M; Kassianides C; Korenman J; Bergasa NV; Baker B; Hoofnagle JH
    J Hepatol; 1990; 11 Suppl 1():S151-4. PubMed ID: 2079575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The interferon therapy of patients with chronic viral hepatitis: the factors affecting the treatment results].
    Kokoreva LN; Zmyzgova AV; Shalygina NB
    Ter Arkh; 1996; 68(2):10-4. PubMed ID: 8771646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of a 12-month course of recombinant human interferon-alpha in chronic delta (type D) hepatitis: a multicenter Italian study.
    Rosina F; Pintus C; Meschievitz C; Rizzetto M
    Hepatology; 1991 Jun; 13(6):1052-6. PubMed ID: 2050321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reaferon treatment in acute HBsAG-positive viral hepatitis].
    Gorbarets IP; Ketiladze ES; Farber NA; Bugaeva NP; Braginskiĭ DM
    Klin Med (Mosk); 1990 Mar; 68(3):65-8. PubMed ID: 2370758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The French experience of treatment of chronic type D hepatitis with a 12-month course of interferon alpha-2B. Results of a randomized controlled trial.
    Gaudin JL; Faure P; Godinot H; Gerard F; Trepo C
    Liver; 1995 Feb; 15(1):45-52. PubMed ID: 7776857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged alpha interferon therapy for chronic delta hepatitis: effect on liver histopathology.
    Kleiner D; Di Bisceglie AM; Axiotis CA; Hoofnagle JH
    Prog Clin Biol Res; 1993; 382():365-71. PubMed ID: 8502705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell function during interferon treatment of delta hepatitis.
    Actis GC; Maran E; Saracco G; Rosina F; Baldi M; Brunetto M
    Prog Clin Biol Res; 1987; 234():305-8. PubMed ID: 3628385
    [No Abstract]   [Full Text] [Related]  

  • 18. Interferon therapy for chronic non-A non-B and chronic delta liver disease in haemophilia.
    Lee CA; Kernoff PB; Karayiannis P; Thomas HC
    Br J Haematol; 1989 Jun; 72(2):235-8. PubMed ID: 2503026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic hepatitis D with interferon alfa-2a.
    Farci P; Mandas A; Coiana A; Lai ME; Desmet V; Van Eyken P; Gibo Y; Caruso L; Scaccabarozzi S; Criscuolo D
    N Engl J Med; 1994 Jan; 330(2):88-94. PubMed ID: 8259188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic delta hepatitis with recombinant human alpha interferon.
    Hoofnagle J; Mullen K; Peters M; Avigan M; Park Y; Waggoner J; Gerin J; Hoyer B; Smedile A
    Prog Clin Biol Res; 1987; 234():291-8. PubMed ID: 3628383
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.